Kranot Hishtalmut Le Morim Tichoniim Havera Menahelet’s iShares Biotechnology ETF IBB Stock Holding History

Kranot Hishtalmut Le Morim Tichoniim Havera Menahelet’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-12,909	Closed	-$1.75M	–	67
2023 Q4	$1.75M	Hold	12,909	–	–	0.35%	72
2023 Q3	$1.6M	Hold	12,909	–	–	0.34%	73
2023 Q2	$1.63M	Hold	12,909	–	–	0.34%	73
2023 Q1	$1.64M	Hold	12,909	–	–	0.37%	72
2022 Q4	$1.7M	Hold	12,909	–	–	0.4%	70
2022 Q3	$1.52M	Hold	12,909	–	–	0.35%	74
2022 Q2	$1.51M	Hold	12,909	–	–	0.33%	74
2022 Q1	$1.67M	Hold	12,909	–	–	0.3%	71
2021 Q4	$1.97M	Hold	12,909	–	–	0.33%	73
2021 Q3	$2.09M	Hold	12,909	–	–	0.38%	68
2021 Q2	$2.11M	Hold	12,909	–	–	0.37%	68
2021 Q1	$1.95M	Hold	12,909	–	–	0.4%	62
2020 Q4	$1.96M	Buy	+12,909	New	+$1.84M	0.44%	58
2017 Q1	–	Sell	-12,063	Closed	-$1.07M	–	31
2016 Q4	$1.07M	Hold	12,063	–	–	1.27%	25
2016 Q3	$1.16M	Buy	+12,063	New	+$1.15M	1.27%	27

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return

Kranot Hishtalmut Le Morim Tichoniim Havera Menahelet's IBB Position: Q1 2024 in Review

Kranot Hishtalmut Le Morim Tichoniim Havera Menahelet sold out of iShares Biotechnology ETF (IBB) in Q1 2024, closing a stake of 12,909 shares — an estimated $1.75M sold.

Kranot Hishtalmut Le Morim Tichoniim Havera Menahelet first reported a position in IBB in Q3 2016 and held it in 15 quarters. The position peaked at $2.11M in Q2 2021. 900 funds tracked by Wall St. Rank hold IBB as of Q1 2024.

Kranot Hishtalmut Le Morim Tichoniim Havera Menahelet reported no remaining iShares Biotechnology ETF position as of Q1 2024 after selling out during the quarter.
Kranot Hishtalmut Le Morim Tichoniim Havera Menahelet sold 12,909 iShares Biotechnology ETF shares in Q1 2024, an estimated $1.75M.
Kranot Hishtalmut Le Morim Tichoniim Havera Menahelet first reported a position in iShares Biotechnology ETF in Q3 2016 and held it in 15 quarters.
Kranot Hishtalmut Le Morim Tichoniim Havera Menahelet's iShares Biotechnology ETF position peaked at $2.11M in Q2 2021.
900 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2024.

Based on Kranot Hishtalmut Le Morim Tichoniim Havera Menahelet's 13F filing for Q1 2024, filed 1 May 2024.